FinancialSpine

Medtronic unveils post-merger management structure

October 30, 2014 by Val Kennedy

Medtronic CEO Omar Ishrak unveils the plan for the medical device giant’s management structure after it closes its mega-merger with Covidien early next year.

Medtronic (NYSE:MDT) CEO Omar Ishrak today unveiled what the medical device giant’s management structure will look like after it closes its mega-merger with Covidien (NYSE:COV) early next year.

According to an employee presentation filed with the SEC, the ‘new’ Medtronic will be comprised of 4 major business segments, headed by Medtronic’s 3 existing group presidents, plus Covidien group president Bryan Hanson.

The Covidien group is slated to oversee all of that company’s current businesses except 2: Covidien’s peripheral vascular business will be merged into Medtronic’s aortic and peripheral unit, while Covidien’s neurovascular business will function as a unit of Medtronic’s restorative therapies group.

READ THE REST AT MASSDEVICE

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button